| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/1991 | US4994475 Method for potentiating an immune response with derivatives |
| 02/19/1991 | US4994474 Hypotensive agents |
| 02/19/1991 | US4994472 1-(pyridinylamino)-2-pyrrolidinones as pain relievers |
| 02/19/1991 | US4994470 Benzopyran derivatives and pharmaceutical compositions containing them |
| 02/19/1991 | US4994469 Diaclyl-substituted methylene-2,2,4-trimethyl-1,2-dihydroquinolines and a process for the preparation thereof |
| 02/19/1991 | US4994467 Treating autism and other developmental disorders in children with NMDA receptor antagonists |
| 02/19/1991 | US4994466 Administering narcotic antagonist |
| 02/19/1991 | US4994461 1,4-dihydropyridine enantiomers |
| 02/19/1991 | US4994460 Treatment or prevention of disorders resulting from central nervous system anoxia |
| 02/19/1991 | US4994458 Spraying a binder solution into fluidized cloud of riboflavin; batch process; free-flowing |
| 02/19/1991 | US4994457 Piroxicam, 5'-guanylic acid, and(or) N-acetyl-L-methionine |
| 02/19/1991 | US4994455 Anti-anxiety agents |
| 02/19/1991 | US4994454 Antibiotic intermediates |
| 02/19/1991 | US4994453 Pyrazolopyridine compound and processes for preparation thereof |
| 02/19/1991 | US4994452 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds |
| 02/19/1991 | US4994451 Temperature stable crystalline salts mixed with base |
| 02/19/1991 | US4994450 Azacyclic compounds and their use as analgesic agents |
| 02/19/1991 | US4994448 Condensed quinolinium and isoquinolinium derivatives |
| 02/19/1991 | US4994447 Method for controlling phytopathogenic fungi using branched aminoalkanephosphonic acids |
| 02/19/1991 | US4994446 Drug system |
| 02/19/1991 | US4994444 Adminstering biodegradable, nontoxic hydroxyethyl starch |
| 02/19/1991 | US4994443 Administering heparin or a derivative thereof and a steroid |
| 02/19/1991 | US4994381 N-[[6-methoxy-5-(trifluoromethyl)-1-naphthalenyl]-thioxomethyl]-N-methylglycine S-oxide and the amide thereof |
| 02/19/1991 | US4994274 Treating glaucoma |
| 02/19/1991 | US4994263 Skin disorders |
| 02/19/1991 | US4994025 Dissolving solvent using halogenated solvent |
| 02/19/1991 | CA2064588A1 Ketotifen preparation for external use |
| 02/19/1991 | CA2039159A1 Nucleic acide fragments and derivated diagnosis reactives from the hhv6/sie genome, and diagnosis process for hhv6 infections |
| 02/19/1991 | CA2037932A1 Methylenediphosphonic acid compound and anti-inflammatory agent containing the compound as effective component |
| 02/19/1991 | CA2023522A1 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(rs)-substitutes, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties |
| 02/19/1991 | CA2023485A1 Macrocyclic compounds |
| 02/19/1991 | CA2021441A1 Process for the manufacture of parenteral application formulations |
| 02/19/1991 | CA1280428C Pyrrolidinylamide ester derivative having anti-prolyl endopeptidase activity and synthesis and use thereof |
| 02/19/1991 | CA1280421C 1,4-disubstituted piperidinyl derivatives |
| 02/19/1991 | CA1280418C 1-phenyl-3-azabicyclo[3.1.1]heptane-2,4 diones, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds |
| 02/19/1991 | CA1280416C Antioestrogenic phenol derivatives |
| 02/19/1991 | CA1280414C Isoprenoidamine derivatives and antiulcer agents |
| 02/19/1991 | CA1280409C Method of producing cephem compounds |
| 02/19/1991 | CA1280408C .beta.-LACTAM ANTIBIOTICS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 02/19/1991 | CA1280372C Treatment of disorders of the gastro-intestinal tract |
| 02/19/1991 | CA1280371C Botulinum toxin neutralizer |
| 02/19/1991 | CA1280370C PHARMACEUTICAL AND DIETARY COMPOSITION CONTAINING .alpha.-LINOLEIC ACID |
| 02/19/1991 | CA1280369C Pharmaceutical with anti-tumor effect |
| 02/19/1991 | CA1280368C Substituted 6h-7, 8-dihydrothiapyrano (3,2-d)- pyrimidines as hypoglycemic agents |
| 02/19/1991 | CA1280366C Topical antimicrobial pharmaceutical composition comprising a silver compound and an azole |
| 02/18/1991 | WO1991002553A2 Transdermal nitroglycerin patch with penetration enhancers |
| 02/18/1991 | WO1991002525A1 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it |
| 02/18/1991 | WO1991002520A1 Pharmaceutical formulations |
| 02/18/1991 | CA2064845A1 Transdermal nitroglycerin patch with penetration enhancers |
| 02/18/1991 | CA2062745A1 Composition based on hydrated lipidic lamellar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical composition, particularly dermatological composition containing it |
| 02/18/1991 | CA2023349A1 Agents for the treatment of conditions of heavy pain and processes for preparing said agents |
| 02/18/1991 | CA2023291A1 Compounds |
| 02/17/1991 | CA2023312A1 Pyrido {3,4-b] [1,4]benzoxazepines, a process for their preparation and their use as medicaments |
| 02/17/1991 | CA2023310A1 Therapeutic agents for the treatment of peptic ulcer disease |
| 02/17/1991 | CA2023303A1 Rapid-onset, gastroprotectant coated aspirin |
| 02/17/1991 | CA2023267A1 Compounds |
| 02/17/1991 | CA2023241A1 1,3-oxazines |
| 02/17/1991 | CA2023233A1 Halogenoalkylphenyl-alcohols, ketones and hydrates thereof |
| 02/17/1991 | CA2023090A1 Cosmetic composition |
| 02/17/1991 | CA2022772A1 Antibiotic composition |
| 02/17/1991 | CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/16/1991 | WO1991002521A1 Antiviral compositions containing sulfoquinovosyl glycerol derivatives and analogs thereof and methods for using the same |
| 02/16/1991 | CA2064772A1 Antiviral compositions containing sulfoquinovosyl glycerol derivatives and analogs thereof and methods for using the same |
| 02/16/1991 | CA2023224A1 Process for preparing 2-deoxy-2, 2-difluoroxylose analogs and intermediates therefor |
| 02/15/1991 | WO1991003226A2 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same |
| 02/15/1991 | CA2064575A1 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same |
| 02/15/1991 | CA2023206A1 Method for increasing salivation for xerostomia patients |
| 02/15/1991 | CA2022892A1 Long active injectable formulations containing triacetin |
| 02/14/1991 | DE3926751A1 Storage stable soln. of alkaloid, esp. atropine - contg. water absorbent beads, esp. mol. sieve, partic. for use in aerosols to deliver very precise doses |
| 02/14/1991 | CA2001458A1 5-methyl-5-deaza-10-propargylaminopterin |
| 02/13/1991 | EP0412941A2 Phospholipids for the treatment of multiple sclerosis |
| 02/13/1991 | EP0412940A2 Hydantoin or imidazolidinetrione derivatives for the prevention or treatment of renal failure |
| 02/13/1991 | EP0412939A2 Certain benzopyran and benzothiopyran derivatives |
| 02/13/1991 | EP0412938A2 System for the treatment of contactlenses |
| 02/13/1991 | EP0412907A2 New organic acid esters of alcoholic derivatives of 19-nor steroids and their salts, process for their preparation and intermediates thereof, their use as medicines and pharmaceutical compositions containing them |
| 02/13/1991 | EP0412901A2 Use of trifluoromethyl-phenyltetrahydropyridines for the manufacture of medicaments for the treatment of intestinal motility |
| 02/13/1991 | EP0412899A2 Oxazolo pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/13/1991 | EP0412898A1 Oxazolo-pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/13/1991 | EP0412877A1 Oral galenic form to improve bioavailability |
| 02/13/1991 | EP0412848A2 Quinoline derivatives, process for their preparation and their use as medicaments |
| 02/13/1991 | EP0412822A2 4,4-Disubstituted piperidine derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 02/13/1991 | EP0412821A2 1-oxa-2-oxo-3,8-diazaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and processes for preparing them |
| 02/13/1991 | EP0412820A2 2-Oxo-1-oxa-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 02/13/1991 | EP0412814A2 Pyridazinones having cardiotonic and beta blocking activity |
| 02/13/1991 | EP0412803A1 Chalcone derivatives |
| 02/13/1991 | EP0412798A2 Substituted pyridines, their preparation, formulations and use in dementia |
| 02/13/1991 | EP0412797A2 The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes |
| 02/13/1991 | EP0412763A2 Cephalosporins, processes for their preparation, pharmaceutical compositions containing them and intermediates therefor |
| 02/13/1991 | EP0412760A2 Benzopyran derivatives |
| 02/13/1991 | EP0412643A1 Flow control system for ink cartridges |
| 02/13/1991 | EP0412641A2 Use of vitamin D in retinopathy |
| 02/13/1991 | EP0412594A2 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists |
| 02/13/1991 | EP0412531A1 Benzopyran compounds, processes for their production and pharmaceutical compositions |
| 02/13/1991 | EP0412529A1 Imidazole derivatives, process for the preparation of the same and antiulcer agents containing the same |
| 02/13/1991 | EP0412470A2 Benzo[b]pyrrolo[3,2,1-jk]benzodiazepines, a process and intermediates for their preparation and their use as medicaments |
| 02/13/1991 | EP0412464A1 Butalactin, a process for its preparation and its use as pharmaceutical |
| 02/13/1991 | EP0412404A2 Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same |
| 02/13/1991 | EP0412387A2 Diarylacetylenes, their process and use |
| 02/13/1991 | EP0412350A2 Renininhibitors, procedure for their preparation and use as medicaments |
| 02/13/1991 | EP0412211A1 Cancer therapy system |